Patent · US Active

Methods of modulating immune responses using BCMA polypeptide

US10494416B2 · kind B2 · utility

1Cited by
13References
7Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMay 15, 2017
Grant dateDec 3, 2019
Priority date
Expiry dateMay 15, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A novel receptor in the TNF family is provided: BAFF-R. Chimeric molecules and antibodies to BAFF-R and methods of use thereof are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.